LEGAL & REGULATORY
Regulatory, Investor and Website Information
Pantarhin provides this information to clarify the investigational status of its pharmaceutical-development activities, the informational nature of investor-related content, corporate relationships and the terms governing use of this website.
Regulatory Information ·Securities Information ·Terms of Use ·Privacy & Data Handling
Regulatory Information
Investigational Pharmaceutical Development
The technologies and pharmaceutical-development programs described on this website are investigational and are presented for scientific, corporate and informational purposes.
No pharmaceutical product based on D016 or developed within the BELACT® program has been approved by the U.S. Food and Drug Administration.
Information concerning D016, BELACT®, preclinical research, biological mechanisms, potential pharmaceutical applications or future development pathways should not be interpreted as evidence of clinical safety, efficacy or therapeutic benefit.
Preclinical or experimental findings are presented only within the context of the respective study design, methodology and limitations and should not be extrapolated directly to outcomes in humans.
Nothing on this website is intended to promote an investigational pharmaceutical product, recommend its use or constitute medical advice, diagnosis or treatment guidance.
Information regarding potential future development activities, indications, clinical studies, regulatory pathways or expedited-development pathways reflects development considerations only and does not imply regulatory authorization, designation, approval, endorsement or confirmation of clinical safety or efficacy.
Investigational·Scientific Information·No Clinical Claims·No Medical Advice
Investor & Securities Information
Corporate Information – No Securities Offered Through This Website
Information provided on this website is intended for general corporate, scientific and informational purposes only.
Nothing on this website constitutes an offer to sell, a solicitation of an offer to purchase, or a recommendation concerning any security, investment product or financing transaction.
Any potential investment, financing or other securities-related transaction involving Pantarhin would be considered separately and, if pursued, would be subject to the applicable U.S. federal and state securities-law framework and definitive transaction documentation.
Any terms, valuations, projections, financial information or investment-related materials made available in connection with a specific discussion would be provided separately and should be evaluated within the context, assumptions, limitations and legal documentation applicable to that discussion.
No statement on this website should be interpreted as a representation or assurance regarding future company value, development success, regulatory approval, commercial performance, investment return or completion of any financing or corporate transaction.
An inquiry, discussion or access to information does not create a subscription, allocation, participation right, transaction entitlement or assurance that any securities or investment opportunity will be made available.
Corporate Information·No Securities Offering·Separate Transaction Process·No Entitlement
Terms of Use / Corporate Legal
Website Use and Corporate Information
This website is operated by Pantarhin Pharma LLC, a limited liability company organized under the laws of the State of Florida, United States.
The information provided on this website is intended for general corporate, scientific and informational purposes and may be updated, modified or withdrawn without prior notice.
While Pantarhin seeks to provide accurate and current information, no representation or warranty is made that all information on this website is complete, current or suitable for any particular purpose.
Use of this website does not create a contractual, advisory, fiduciary, medical, investment or other professional relationship between Pantarhin and the user.
Nothing on this website grants any right in D016, BELACT®, patents, technology, development activities, confidential information or other intellectual property except as expressly provided in applicable written documentation.
Governing Law and Jurisdiction
These Terms are governed by the laws of the State of Florida, subject to applicable mandatory law. Disputes relating to these Terms or use of this website are subject to the jurisdiction of courts in Florida, unless applicable mandatory law requires otherwise.
Intellectual Property and Website Content
Unless otherwise indicated, website content, trademarks, names, texts, graphics and other materials are owned by or used with permission by Pantarhin or the respective rights holder.
Nothing on this website grants any license or other right to use patents, trademarks, proprietary technology or other intellectual property except as expressly stated in writing.
Florida LLC·Website Information·Governing Law·No Implied Rights
Corporate Relationships
Separate Legal Entities and Defined Rights
Pantarhin Pharma LLC is an independent U.S. company working with Pharmact Holding AG, Switzerland, in defined areas of pharmaceutical development, intellectual property, regulatory strategy and partnering.
References to Pharmact Holding AG or other partner companies describe defined corporate, development, intellectual-property or partnering relationships. Unless expressly stated otherwise, each company remains a separate legal entity.
References to D016 or BELACT® do not by themselves establish ownership of the underlying technology, unrestricted development rights, licensing authority or commercialization rights.
Access to technology, material, information or development activities does not by itself establish ownership, licensing rights, exclusivity, agency or authority to bind another entity.
Rights and responsibilities are determined by the applicable corporate, intellectual-property and contractual documentation. Rights and disclosures are defined by agreement – not inferred from access to material or information.
Separate Legal Entities·Defined Rights·No Implied License·Contractual Framework
Privacy & Data Handling
Information Submitted Through This Website
Pantarhin may process information voluntarily submitted through this website for the purpose of reviewing, responding to and appropriately routing scientific, corporate, strategic or investor-related inquiries.
Users should provide only information necessary for the respective inquiry.
Please do not submit patient information, medical records, health or genetic data, or other sensitive personal data through general website contact forms.
Please do not submit confidential or proprietary third-party information unless appropriate confidentiality arrangements have been established separately.
Submission of information through this website does not create a non-disclosure agreement, confidentiality obligation, investment relationship or other professional relationship.
The processing of personal information is described in the separate Privacy Policy.
Purpose-Limited Processing·No Patient Data·Separate Privacy Policy·Confidentiality Where Agreed
Terms Acceptance & Electronic Contact
Use of Contact and Inquiry Forms
Before submitting a contact, strategic or investor-related inquiry, users are required to agree to the Terms of Use and acknowledge that the Privacy Policy has been made available.
Submission of a website form is not possible without this confirmation.
Information submitted through the website is transmitted for the purpose of reviewing and responding to the respective inquiry and may be routed internally to the appropriate responsible person.
Electronic submission of an inquiry does not create a contractual, advisory, fiduciary, medical, investment or other professional relationship with Pantarhin.
Where confidential information is intended to be exchanged, confidentiality should be established separately in writing before such information is provided.
Terms Agreement·Privacy Acknowledgment·Appropriate Routing·Separate Confidentiality
Future-Oriented Information
Development Plans and Future Events
Certain information on this website may relate to future development activities, potential indications, regulatory pathways, scientific hypotheses, intellectual-property considerations, strategic partnerships, financing activities or other future events.
Such information reflects current plans, considerations or expectations at the time of publication and may change as scientific evidence, regulatory requirements, development priorities, financing, operational conditions or other circumstances evolve.
References to potential development pathways, regulatory activities, patent term extension, clinical investigation, partnerships, financing or commercialization should not be interpreted as assurances that such events will occur.
Future development is subject to scientific, regulatory, technical, legal, financial, operational and strategic uncertainty. No assurance is given regarding clinical outcome, approval, designation, transaction completion, financing success or commercial performance.
Pantarhin does not undertake through this website to update every statement immediately when circumstances, plans or development priorities change.
Current Information·Future Uncertainty·No Assurance·Development May Change
Third-Party References & External Content
Third-Party Names, References and Links
This website may refer to third-party organizations, scientific institutions, regulatory authorities, publications, patents or other external sources for informational purposes.
Reference to a third party does not imply endorsement, sponsorship, partnership, validation or approval by that third party unless expressly stated.
Third-party names, trademarks and other proprietary rights remain the property of their respective owners.
Links to external websites are provided for convenience and informational purposes. Pantarhin does not control external content and is not responsible for its availability, accuracy, completeness or subsequent modification.
Scientific, regulatory or patent-related references should be interpreted within the context of the underlying source and should not be considered independent confirmation of broader conclusions.
Third-Party References·No Implied Endorsement·External Sources·Source Context
Website Availability & Limitation of Liability
Use of Website Information
This website and its content are provided for general informational purposes.
Pantarhin does not guarantee uninterrupted availability of the website or that all content will remain continuously accessible, error-free or unchanged.
Users should not rely on website information as the sole basis for medical, scientific, regulatory, legal, financial, investment or other professional decisions.
To the extent permitted by applicable law, Pantarhin is not responsible for losses or damages arising solely from reliance on general website information, temporary website unavailability or the use of third-party content or external links.
Nothing in these Terms is intended to exclude or limit liability where such exclusion or limitation is prohibited by applicable law.
General Information·No Sole Reliance·Website Availability·Subject to Applicable Law
Changes, Severability & Version
Changes to These Terms
Pantarhin may revise these Terms of Use when legal, regulatory, technical or operational requirements change.
The version published on this website at the time of use applies to the respective website interaction.
Material changes may be identified through an updated effective date or version reference.
If any provision of these Terms is found to be invalid, unlawful or unenforceable, the remaining provisions will remain in effect to the extent permitted by applicable law.
Failure by Pantarhin to exercise or enforce any right under these Terms does not constitute a waiver of that right.
Contact
Questions concerning these Terms of Use or the operation of this website may be directed to:
Pantarhin Pharma LLC
Florida, United States
Email: info@pantarhin.com
Effective Date: September 2026
Version: 1.1
Current Terms·Version Control·Severability·Legal Contact